JPY 507.0
(-0.39%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 8.89 Billion JPY | 1.36% |
2022 | 8.77 Billion JPY | 0.52% |
2021 | 8.73 Billion JPY | 7.63% |
2020 | 8.11 Billion JPY | 6.51% |
2019 | 7.61 Billion JPY | 0.7% |
2018 | 7.56 Billion JPY | -1.03% |
2017 | 7.64 Billion JPY | -10.17% |
2016 | 8.5 Billion JPY | -11.73% |
2015 | 9.63 Billion JPY | 21.66% |
2014 | 7.92 Billion JPY | -5.58% |
2013 | 8.39 Billion JPY | 39.38% |
2012 | 6.02 Billion JPY | -4.43% |
2011 | 6.29 Billion JPY | 0.88% |
2010 | 6.24 Billion JPY | 0.68% |
2009 | 6.2 Billion JPY | 7.55% |
2008 | 5.76 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 8.64 Billion JPY | -5.98% |
2024 Q2 | 9.19 Billion JPY | 6.16% |
2024 Q1 | 8.65 Billion JPY | -2.69% |
2023 FY | 8.89 Billion JPY | 1.36% |
2023 Q2 | 9.5 Billion JPY | -2.31% |
2023 Q1 | 9.72 Billion JPY | 10.81% |
2023 Q4 | 8.89 Billion JPY | -1.24% |
2023 Q3 | 9 Billion JPY | -5.19% |
2022 Q2 | 8.93 Billion JPY | -5.88% |
2022 FY | 8.77 Billion JPY | 0.52% |
2022 Q4 | 8.77 Billion JPY | -3.67% |
2022 Q3 | 9.11 Billion JPY | 1.95% |
2022 Q1 | 9.49 Billion JPY | 8.74% |
2021 Q2 | 9.21 Billion JPY | 4.17% |
2021 FY | 8.73 Billion JPY | 7.63% |
2021 Q1 | 8.84 Billion JPY | 9.02% |
2021 Q3 | 8.25 Billion JPY | -10.45% |
2021 Q4 | 8.73 Billion JPY | 5.84% |
2020 FY | 8.11 Billion JPY | 6.51% |
2020 Q3 | 8.72 Billion JPY | -6.77% |
2020 Q1 | 8.02 Billion JPY | 5.29% |
2020 Q2 | 9.36 Billion JPY | 16.74% |
2020 Q4 | 8.11 Billion JPY | -7.06% |
2019 Q3 | 8.25 Billion JPY | -8.14% |
2019 Q4 | 7.61 Billion JPY | -7.66% |
2019 Q1 | 8.36 Billion JPY | 10.52% |
2019 FY | 7.61 Billion JPY | 0.7% |
2019 Q2 | 8.98 Billion JPY | 7.42% |
2018 Q1 | 8.52 Billion JPY | 11.52% |
2018 Q4 | 7.56 Billion JPY | -10.28% |
2018 Q3 | 8.43 Billion JPY | -1.47% |
2018 FY | 7.56 Billion JPY | -1.03% |
2018 Q2 | 8.55 Billion JPY | 0.4% |
2017 Q4 | 7.64 Billion JPY | -4.74% |
2017 Q2 | 8.62 Billion JPY | 0.3% |
2017 Q1 | 8.6 Billion JPY | 1.12% |
2017 FY | 7.64 Billion JPY | -10.17% |
2017 Q3 | 8.02 Billion JPY | -7.01% |
2016 Q4 | 8.5 Billion JPY | -3.89% |
2016 FY | 8.5 Billion JPY | -11.73% |
2016 Q2 | 9.13 Billion JPY | -8.79% |
2016 Q3 | 8.85 Billion JPY | -3.11% |
2016 Q1 | 10.01 Billion JPY | 3.92% |
2015 Q3 | 10.1 Billion JPY | 1.23% |
2015 Q4 | 9.63 Billion JPY | -4.65% |
2015 Q2 | 9.98 Billion JPY | 2.42% |
2015 FY | 9.63 Billion JPY | 21.66% |
2015 Q1 | 9.75 Billion JPY | 23.06% |
2014 Q3 | 8.29 Billion JPY | -6.31% |
2014 Q2 | 8.85 Billion JPY | -0.2% |
2014 Q1 | 8.86 Billion JPY | 5.69% |
2014 FY | 7.92 Billion JPY | -5.58% |
2014 Q4 | 7.92 Billion JPY | -4.46% |
2013 Q1 | 7.07 Billion JPY | 17.5% |
2013 Q2 | 7.87 Billion JPY | 11.31% |
2013 Q3 | 8.94 Billion JPY | 13.61% |
2013 Q4 | 8.39 Billion JPY | -6.19% |
2013 FY | 8.39 Billion JPY | 39.38% |
2012 Q3 | 5.91 Billion JPY | -16.22% |
2012 Q4 | 6.02 Billion JPY | 1.71% |
2012 Q1 | 7.19 Billion JPY | 14.19% |
2012 Q2 | 7.06 Billion JPY | -1.78% |
2012 FY | 6.02 Billion JPY | -4.43% |
2011 Q4 | 6.29 Billion JPY | 1.26% |
2011 Q2 | 7.09 Billion JPY | -1.94% |
2011 Q1 | 7.23 Billion JPY | 15.87% |
2011 FY | 6.29 Billion JPY | 0.88% |
2011 Q3 | 6.22 Billion JPY | -12.31% |
2010 Q3 | 5.74 Billion JPY | -12.44% |
2010 Q4 | 6.24 Billion JPY | 8.76% |
2010 Q2 | 6.55 Billion JPY | 10.07% |
2010 FY | 6.24 Billion JPY | 0.68% |
2010 Q1 | 5.95 Billion JPY | -3.95% |
2009 FY | 6.2 Billion JPY | 7.55% |
2009 Q4 | 6.2 Billion JPY | 0.0% |
2008 FY | 5.76 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Kitanotatsujin Corporation | 1.65 Billion JPY | -438.344% |
Euglena Co., Ltd. | 37.92 Billion JPY | 76.538% |
BEAUTY GARAGE Inc. | 6.49 Billion JPY | -37.039% |
Axas Holdings Co.,Ltd. | 14.58 Billion JPY | 38.979% |
C.I. Medical Co.,Ltd. | 21.36 Billion JPY | 58.36% |
Kao Corporation | 757.7 Billion JPY | 98.826% |
Niitaka Co., Ltd. | 9.35 Billion JPY | 4.907% |
Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 91.025% |
Shiseido Company, Limited | 615.1 Billion JPY | 98.554% |
Lion Corporation | 188.22 Billion JPY | 95.273% |
Mandom Corporation | 20.05 Billion JPY | 55.638% |
Ivy Cosmetics Corporation | 1.32 Billion JPY | -570.582% |
Milbon Co., Ltd. | 7.45 Billion JPY | -19.273% |
Nippon Shikizai, Inc. | 13.56 Billion JPY | 34.387% |
Fancl Corporation | 30.56 Billion JPY | 70.894% |
KOSÉ Corporation | 88.61 Billion JPY | 89.96% |
Cota Co., Ltd. | 3.85 Billion JPY | -130.94% |
HABA Laboratories,Inc. | 3.92 Billion JPY | -126.734% |
C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | -182.556% |
Pola Orbis Holdings Inc. | 33.26 Billion JPY | 73.25% |
Noevir Holdings Co., Ltd. | 24.04 Billion JPY | 62.991% |
Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -736.138% |
Almado, Inc. | 1.94 Billion JPY | -357.119% |
I-ne CO., LTD. | 8.57 Billion JPY | -3.722% |
Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | -82.321% |
Liberta Co.,Ltd. | 3.88 Billion JPY | -129.1% |
AXXZIA Inc. | 2 Billion JPY | -343.433% |
S.T. Corporation | 12.01 Billion JPY | 25.924% |
Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 85.8% |
Earth Corporation | 60.4 Billion JPY | 85.271% |
Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | -14.094% |
Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -451.582% |
Ya-Man Ltd. | 3.97 Billion JPY | -123.751% |
MTG Co., Ltd. | 11.73 Billion JPY | 24.208% |
TRANSACTION CO.,Ltd. | 4.17 Billion JPY | -113.258% |
Artnature Inc. | 23.42 Billion JPY | 62.021% |
Pigeon Corporation | 19.34 Billion JPY | 54.017% |
Unicharm Corporation | 345.37 Billion JPY | 97.424% |
Paltac Corporation | 222.34 Billion JPY | 95.998% |
CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | 68.797% |